Hexa-acylated lipopolysaccharides from the gut microbiota are associated with efficacy in patients with cancer receiving anti-PD-1 and stimulate host immune activation for enhanced anti-tumour immunity in mouse models.
- Puspendu Sardar
- Benjamin S. Beresford-Jones
- Virginia A. Pedicord